A new study Journal of Molecular and Cellular Cardiology Plus demonstrates how RNA biomarkers may be used to confirm heart disease.
Category: Heart Disease
The campaign is focused on empowering patients with lung cancer and their caregivers to initiate a dialogue with their physicians about comprehensive genomic testing and its potential to expand treatment options for the patient.Read More
Analysis utilizing single-molecule counting technology developed by Singulex has shown the power to identify patients at risk for worsening heart health.Read More
Abridged and edited results of a live Q&A session with Donna Mayne, BS, MT(ASCP), (CLS)NCA, microbiology and molecular laboratory manager at Sacred Heart Hospital Pensacola Laboratory, during CLP’s well-attended webcast on “Bacterial Vaginosis: Complications and Diagnostic Options.”Read More
Researchers seek to better understand the genomic basis of disease, and provide tailored care to patients.Read More
Reshaping and broadening the future of lab testing, these diagnostic advances are particularly noteworthy for laboratorians as well as for physicians and patients.Read More
With the prevalence of diabetes continuing on an upward trajectory both in the United States and overseas, healthcare professionals are continuing to search for more effective methods of preventing, detecting, and treating the disease.Read More